Director of Operations and Science …

On August 20, 2024, Steve Miller, Chief Operating & Scientific Officer of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), sold 150,000 shares of the company. The transaction was documented in a recent SEC filing. After this sale, the insider now owns 675,124 shares…